• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构和基于配体的方法相结合的计算药物设计。

Integrating structure-based and ligand-based approaches for computational drug design.

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.

出版信息

Future Med Chem. 2011 Apr;3(6):735-50. doi: 10.4155/fmc.11.18.

DOI:10.4155/fmc.11.18
PMID:21554079
Abstract

Methods utilized in computer-aided drug design can be classified into two major categories: structure based and ligand based, using information on the structure of the protein or on the biological and physicochemical properties of bound ligands, respectively. In recent years there has been a trend towards integrating these two methods in order to enhance the reliability and efficiency of computer-aided drug-design approaches by combining information from both the ligand and the protein. This trend resulted in a variety of methods that include: pseudoreceptor methods, pharmacophore methods, fingerprint methods and approaches integrating docking with similarity-based methods. In this article, we will describe the concepts behind each method and selected applications.

摘要

计算机辅助药物设计中使用的方法可以分为两类

基于结构和基于配体的方法,分别利用蛋白质结构信息和结合配体的生物和物理化学性质信息。近年来,有一种趋势是将这两种方法结合起来,通过结合配体和蛋白质的信息来提高计算机辅助药物设计方法的可靠性和效率。这种趋势导致了各种方法的出现,包括:伪受体方法、药效团方法、指纹方法以及将对接与基于相似性的方法相结合的方法。在本文中,我们将描述每种方法的概念和选定的应用。

相似文献

1
Integrating structure-based and ligand-based approaches for computational drug design.基于结构和基于配体的方法相结合的计算药物设计。
Future Med Chem. 2011 Apr;3(6):735-50. doi: 10.4155/fmc.11.18.
2
Importance of molecular computer modeling in anticancer drug development.分子计算机建模在抗癌药物研发中的重要性。
J BUON. 2007 Sep;12 Suppl 1:S101-18.
3
Recent developments in de novo design and scaffold hopping.从头设计和骨架跃迁的最新进展。
Curr Opin Drug Discov Devel. 2008 May;11(3):365-74.
4
The use of protein-ligand interaction fingerprints in docking.蛋白质-配体相互作用指纹图谱在对接中的应用。
Curr Opin Drug Discov Devel. 2008 May;11(3):356-64.
5
Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.基于结构的可药性评估——确定小分子治疗药物的合适靶点。
Curr Opin Chem Biol. 2011 Aug;15(4):463-8. doi: 10.1016/j.cbpa.2011.05.020. Epub 2011 Jun 23.
6
[An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery].[计算机辅助基于结构的药物设计简介——生物信息学在药物发现中的应用]
Rinsho Byori. 2002 Jan;50(1):45-51.
7
Combining structure-based drug design and pharmacophores.结合基于结构的药物设计和药效团。
J Mol Graph Model. 2005 Apr;23(5):439-46. doi: 10.1016/j.jmgm.2004.12.001.
8
Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.用于药物化学、药物设计和化学信息学培训的分子概念器。
Chem Biol Drug Des. 2007 Jan;69(1):75-82. doi: 10.1111/j.1747-0285.2007.00465.x.
9
Towards structure-based protein drug design.迈向基于结构的蛋白质药物设计。
Biochem Soc Trans. 2011 Oct;39(5):1382-6, suppl 1 p following 1386. doi: 10.1042/BST0391382.
10
Chemical informatics: using molecular shape descriptors in structure-based drug design.化学信息学:在基于结构的药物设计中使用分子形状描述符。
Methods Mol Biol. 2012;841:235-50. doi: 10.1007/978-1-61779-520-6_10.

引用本文的文献

1
Developing muscarinic receptor M1 classification models utilizing transfer learning and generative AI techniques.利用迁移学习和生成式人工智能技术开发毒蕈碱受体M1分类模型。
Sci Rep. 2025 May 12;15(1):16486. doi: 10.1038/s41598-025-00972-w.
2
Prediction of SafD adhesin strong binding peptides for pilus proteins assembly suppression in the prevention of -induced biofilm formation using virtual mutagenesis studies.使用虚拟诱变研究预测SafD黏附素强结合肽以抑制菌毛蛋白组装,预防[具体因素]诱导的生物膜形成
In Silico Pharmacol. 2025 Feb 10;13(1):25. doi: 10.1007/s40203-025-00313-9. eCollection 2025.
3
Virtual screening: hope, hype, and the fine line in between.
虚拟筛选:希望、炒作与二者之间的微妙界限。
Expert Opin Drug Discov. 2025 Feb;20(2):145-162. doi: 10.1080/17460441.2025.2458666. Epub 2025 Jan 27.
4
Bridging Structure- and Ligand-Based Virtual Screening through Fragmented Interaction Fingerprint.通过碎片化相互作用指纹连接基于结构和配体的虚拟筛选
ACS Omega. 2024 Sep 3;9(37):38957-38969. doi: 10.1021/acsomega.4c05433. eCollection 2024 Sep 17.
5
Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases.热休克蛋白90在2型糖尿病中的作用及其与肝脏疾病的关联。
Mol Biotechnol. 2024 Aug 20. doi: 10.1007/s12033-024-01251-1.
6
Structure-Activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds.血管内皮生长因子受体 2(VEGFR2)酪氨酸激酶抑制剂的构效关系研究,以鉴定潜在的天然抗癌化合物。
Med Chem. 2024;20(6):646-661. doi: 10.2174/0115734064247526231129080415.
7
Fighting Antimicrobial Resistance: Insights on How the NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations.抗击抗微生物药物耐药性:通过监督分子动力学(SuMD)和分子对接模拟研究 NorA 外排泵识别 2-苯基喹啉抑制剂的见解。
J Chem Inf Model. 2023 Aug 14;63(15):4875-4887. doi: 10.1021/acs.jcim.3c00516. Epub 2023 Jul 29.
8
Recent Advances in Computer-Aided Structure-Based Drug Design on Ion Channels.离子通道的计算机辅助基于结构的药物设计的最新进展。
Int J Mol Sci. 2023 May 25;24(11):9226. doi: 10.3390/ijms24119226.
9
Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer.设计、合成、动力学分析及基于药效团的 3-乙胺基-亚氨噻唑啉酮类碳酸酐酶 II 抑制剂的发现:一种用于癌症治疗的新兴生物靶标。
Biomolecules. 2022 Nov 16;12(11):1696. doi: 10.3390/biom12111696.
10
Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance.计算技术在抗癌研究中的新兴前景:概览
Bioengineering (Basel). 2022 Jul 25;9(8):335. doi: 10.3390/bioengineering9080335.